Siemens Healthineers
333 Coney St
East Walpole
MA
02032
United States
Tel: 508-668-5000
71 articles about Siemens Healthineers
-
Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance
6/1/2020
Total antibody test has demonstrated 100 percent sensitivity and 99.8 percent specificity in identifying SARS-CoV-2 antibodies. The test detects the antibodies believed to neutralize the SARS-CoV-2 virus; specifically targeting antibodies that attach to a spike protein on the surface of the virus. The test is available on the company’s high-throughput analyzers that can deliver up to 440 tests/hour 1 and report results in as few as 10 minut
-
Siemens Healthineers Now Shipping Worldwide Total Antibody Test and Molecular Test Kit for COVID-19 with Expanded Capacity
5/26/2020
Siemens Healthineers started shipping its total antibody tests globally, including to the largest analyzer installed base in the U.S. The company has a total of 20,000 systems worldwide and will ramp up its production capacity of more than 50 million antibody tests per month as the pandemic evolves.
-
Corindus Announces New Clinical Data Showing 20 Percent Reduction in Patient Radiation Exposure with Robotic-assisted Intervention
5/18/2020
Clinical evidence shows significant patient radiation reduction with CorPath® GRX Vascular Robotic System
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
-
Siemens Healthineers Releases Test Kit for Coronavirus COVID-19
4/2/2020
Siemens Healthineers announced the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.
-
FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings
3/31/2020
Siemens Healthineers announced today that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration.
-
Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution
2/3/2020
Quest plans to standardize its immunoassay testing across 19 core laboratories, including a new flagship lab in Clifton, New Jersey with Atellica Solution and automation
-
Siemens Healthineers and Hamilton Health Sciences announce formation of new Value Partnership to enhance imaging services in southwestern Ontario
1/30/2020
Value partnership over 15-year period will see the provision of the latest imaging equipment to transform care delivery for patients across southwestern Ontario
-
At RSNA, Siemens Healthineers Debuts SOMATOM On.site To Enable CT Head Exams at Patient’s Bedside
12/1/2019
Mobile CT scanner enables patient to remain in the ICU while connected to monitors and devices
-
FDA Clears Siemens Healthineers SOMATOM X.cite CT Scanner With Intelligent User Interface Concept
11/21/2019
myExam Companion intelligent user interface concept guides technologists through complex clinical tasks
-
Neuroradiologist in Toronto Performs World’s First Robotic-Assisted Aneurysm Coiling Using Corindus Technology
11/5/2019
Novel procedure marks a pivotal step in implementation of robotics to address neurovascular disease
-
Gryphon Investors Announces Pending Sale of ECG Management Consultants
9/30/2019
Gryphon Investors, a San Francisco-based middle-market private equity firm, announced that it has entered definitive documentation to sell its portfolio company ECG Management Consultants to Siemens Medical Solutions USA, Inc., a subsidiary of Siemens Healthineers AG.
-
Survey: Discomfort May Deter Large Number of Women From Obtaining Mammograms
9/25/2019
Siemens Healthineers and HealthyWomen, the nation’s leading independent, nonprofit health information source for women, today announced results from a new national survey designed to deepen understanding on how to improve women’s experiences with screening mammograms for breast cancer detection.
-
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Corindus Vascular Robotics, Inc. (NYSE: CVRS) on Behalf of Corindus Shareholders and Encourages Corindus Investors to Contact the Firm
8/8/2019
Pursuant to the proposed transaction, announced on August 8, 2019 and valued at $1.1 billion, Corindus shareholders will receive $4.28 in cash for each share of Corindus common stock owned.
-
Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers
8/8/2019
Corindus Vascular Robotics announced that it has entered into a definitive merger agreement to be acquired by Siemens Healthineers AG.
-
Siemens Healthineers Earns Acclaim from Frost & Sullivan for Employing AI to Reduce Variability in Imaging
7/24/2019
The company's holistic product line generates highly precise images for improved patient outcomes
-
Siemens Healthineers Exhibits Solutions That Drive Outcomes That Matter to Healthcare Providers and Patients
5/16/2019
Siemens Healthineers will showcase its unique, customizable offerings for in vitro diagnostics testing designed to improve workflow, efficiency and clinical outcomes.
-
Siemens Healthineers Hemoglobin A1c Test for Diagnosing and Monitoring Diabetes Now Available on the Atellica Solution
5/14/2019
Siemens Healthineers announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes, a growing and potentially deadly disease.
-
10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
12/4/2018
Siemens Healthineers invested $300M in the Walpole, Mass. laboratory diagnostics manufacturing facility bringing up to 700 local, high-tech jobs to Massachusetts.
-
Multimillion-Dollar Investment in the Atellica Solution will Transform Pathology Testing across Australia
11/7/2018
Siemens Healthineers and Primary Health Care team up to revolutionize healthcare outcomes in pathology.